Aytu Biopharma (AYTU) EPS (Basic) Growth (3y) (2017 - 2025)
Aytu Biopharma (AYTU) EPS (Basic) Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | 34.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -90.31% |
| Mar 31, 2025 | 26.00% |
| Dec 31, 2024 | 26.04% |
| Sep 30, 2024 | 26.05% |
| Jun 30, 2024 | 79.31% |
| Dec 31, 2023 | 78.03% |
| Sep 30, 2023 | 74.46% |
| Jun 30, 2023 | 71.63% |
| Mar 31, 2023 | 60.02% |
| Dec 31, 2022 | 67.33% |
| Sep 30, 2022 | 83.71% |
| Jun 30, 2022 | 26.83% |
| Mar 31, 2022 | 28.73% |
| Dec 31, 2021 | 60.74% |
| Sep 30, 2021 | 62.02% |
| Jun 30, 2021 | 74.66% |
| Dec 31, 2020 | 84.79% |
| Sep 30, 2020 | 90.20% |
| Jun 30, 2020 | 91.76% |
| Mar 31, 2020 | 90.57% |